These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 2044014)

  • 21. Experience of long term treatment and different dosage regimens of isosorbide 5-mononitrate.
    Meffert M; Paeckelmann IM
    Drugs; 1987; 33 Suppl 4():104-10. PubMed ID: 3622314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
    Uusitalo A
    Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of effect of asymmetrical dosage timing of isosorbide-5-mononitrate on nitrate tolerance during long-term administration.
    Hughes LO; DasGupta P; Jain D; Lahiri A; Raftery EB
    Eur J Clin Pharmacol; 1989; 36(2):139-44. PubMed ID: 2498105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
    Chen YH; Ding PY; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained effect of orally administered isosorbide dinitrate on exercise performance of patients with angina pectoris.
    Markis JE; Gorlin R; Mills RM; Williams RA; Schweitzer P; Ransil BJ
    Am J Cardiol; 1979 Feb; 43(2):265-71. PubMed ID: 367136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of slow-release isosorbide-5-mononitrate on ergometric parameters and cardiac output in stable effort angina pectoris: a double-blind randomized placebo study].
    Romeo F; Barillà F; Pelliccia F; Ferraironi A; Ciolli A; Pannarale G; Vicchio D; Valente A
    Cardiologia; 1989 Jul; 34(7):643-50. PubMed ID: 2676173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina.
    Akhras F; Jackson G
    Lancet; 1991 Oct; 338(8774):1036-9. PubMed ID: 1681355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting isosorbide mononitrate.
    Prakash A; Markham A
    Drugs; 1999 Jan; 57(1):93-9; discussion 100. PubMed ID: 9951954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Isosorbide 5-mononitrate (delayed release) in stable effort angina].
    Almenar Bonet L; Miró Palau V; Gimeno Gascón JV; Algarra Vidal F
    Rev Esp Cardiol; 1992; 45(7):456-61. PubMed ID: 1439070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tolerance to a sustained release form of isosorbide dinitrate: comparison between 20 mg four times and 40 mg twice-daily administrations].
    Hiasa Y; Hamai K; Wada T; Ootani R; Shinohara H; Aihara T; Bando M; Nakai Y; Kataoka Y
    Kokyu To Junkan; 1991 Sep; 39(9):925-30. PubMed ID: 1749871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report.
    Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R
    Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of intervals between doses on the development of tolerance to isosorbide dinitrate.
    Parker JO; Farrell B; Lahey KA; Moe G
    N Engl J Med; 1987 Jun; 316(23):1440-4. PubMed ID: 3574424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intraindividual dose-response relationship of sustained-release Elantan].
    Kenedi P
    Z Kardiol; 1986; 75 Suppl 3():77-9. PubMed ID: 3541420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 39. Transdermal isosorbide dinitrate in angina pectoris: effect of acute and sustained therapy.
    Parker JO; VanKoughnett KA; Fung HL
    Am J Cardiol; 1984 Jul; 54(1):8-13. PubMed ID: 6430057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris.
    Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H
    Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.